A newly identified G-quadruplex as a potential target regulating Bcl-2 expression.

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• A G-quadruplex structure in the B-cell CLL/lymphoma 2 (Bcl-2) P1 promoter was investigated.
• Its role in Bcl-2 transcription was studied to identify potential anticancer targets.

Purpose of the Study:

• To characterize a novel G-quadruplex structure in the Bcl-2 P1 promoter.
• To assess its physiological function and interaction with small molecules.
• To evaluate its potential as an anticancer therapeutic target.

Main Methods:

• G-quadruplex structure determination using UV-melting, polyacrylamide gel electrophoresis, circular dichroism, and nuclear magnetic resonance.
• Interaction studies with a phenanthroline derivative using fluorescence spectroscopy.
• Functional assessment via real-time polymerase chain reaction and luciferase assays.

Main Results:

• The p32 DNA sequence forms an intramolecular hybrid-type G-quadruplex.
• A phenanthroline derivative binds with high affinity and modulates the G-quadruplex conformation.
• The phenanthroline derivative down-regulates Bcl-2 transcription in a concentration-dependent manner.
• Functional effects were dependent on the intact G-quadruplex structure.

Conclusions:

• A novel G-quadruplex in the Bcl-2 P1 promoter is intrinsically linked to Bcl-2 transcription.
• This G-quadruplex represents a promising novel anticancer therapeutic target.